Figure 1
(A) Schematic overview for the experimental design used. (B–I) Immunostaining of pluripotency markers (Nanog, Oct4, SSEA4, TRA-1-60-R) in iPSC and in ESC.
Figure 1 | Scientific Reports
(A) Schematic overview for the experimental design used. (B–I) Immunostaining of pluripotency markers (Nanog, Oct4, SSEA4, TRA-1-60-R) in iPSC and in ESC.
